Primecap Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.15M Hold
97,168
﹤0.01% 292
2026
Q1
$4.68M Hold
97,168
﹤0.01% 281
2025
Q4
$4.71M Sell
97,168
-889,300
-90% -$44.1M ﹤0.01% 279
2025
Q3
$46.6M Sell
986,468
-149,060
-13% -$7.19M 0.04% 199
2025
Q2
$54.9M Buy
1,135,528
+34,890
+3% +$1.78M 0.04% 190
2025
Q1
$61M Sell
1,100,638
-10,290
-0.9% -$557K 0.05% 168
2024
Q4
$53.6M Sell
1,110,928
-5,070
-0.5% -$258K 0.04% 181
2024
Q3
$64.3M Sell
1,115,998
-1,330
-0.1% -$71.8K 0.05% 169
2024
Q2
$54.2M Sell
1,117,328
-2,122
-0.2% -$102K 0.04% 183
2024
Q1
$54.4M Sell
1,119,450
-3,580
-0.3% -$175K 0.04% 184
2023
Q4
$55.8M Sell
1,123,030
-3,960
-0.4% -$194K 0.04% 178
2023
Q3
$60.5M Sell
1,126,990
-5,100
-0.5% -$272K 0.05% 165
2023
Q2
$61M Sell
1,132,090
-56,960
-5% -$3.06M 0.05% 165
2023
Q1
$64.7M Sell
1,189,050
-26,690
-2% -$1.3M 0.06% 159
2022
Q4
$58.9M Sell
1,215,740
-23,760
-2% -$1.04M 0.05% 167
2022
Q3
$47.1M Hold
1,239,500
0.05% 176
2022
Q2
$62M Sell
1,239,500
-5,940
-0.5% -$315K 0.06% 165
2022
Q1
$63.9M Sell
1,245,440
-4,420
-0.4% -$228K 0.05% 174
2021
Q4
$62.6M Sell
1,249,860
-98,500
-7% -$4.87M 0.04% 181
2021
Q3
$65M Sell
1,348,360
-31,750
-2% -$1.61M 0.05% 182
2021
Q2
$72.7M Sell
1,380,110
-12,480
-0.9% -$651K 0.05% 174
2021
Q1
$68.9M Sell
1,392,590
-310,970
-18% -$14.9M 0.05% 176
2020
Q4
$82.8M Sell
1,703,560
-38,610
-2% -$1.9M 0.06% 159
2020
Q3
$87.4M Sell
1,742,170
-75,470
-4% -$3.89M 0.07% 145
2020
Q2
$92.8M Sell
1,817,640
-42,900
-2% -$2.08M 0.08% 137
2020
Q1
$81.3M Sell
1,860,540
-49,760
-3% -$2.38M 0.08% 133
2019
Q4
$95.9M Buy
1,910,300
+6,000
+0.3% +$281K 0.07% 144
2019
Q3
$88.2M Sell
1,904,300
-16,400
-0.9% -$707K 0.07% 145
2019
Q2
$83.1M Sell
1,920,700
-35,000
-2% -$1.49M 0.06% 152
2019
Q1
$86.6M Hold
1,955,700
0.06% 152
2018
Q4
$84.9M Hold
1,955,700
0.07% 144
2018
Q3
$87.4M Sell
1,955,700
-300
-0% -$12.8K 0.06% 152
2018
Q2
$78.3M Hold
1,956,000
0.06% 148
2018
Q1
$78.4M Hold
1,956,000
0.06% 152
2017
Q4
$84.1M Sell
1,956,000
-10,014
-0.5% -$462K 0.06% 152
2017
Q3
$97.9M Sell
1,966,014
-16,693
-0.8% -$808K 0.08% 146
2017
Q2
$95M Sell
1,982,707
-42,100
-2% -$2.01M 0.08% 145
2017
Q1
$91.6M Sell
2,024,807
-12,400
-0.6% -$526K 0.08% 139
2016
Q4
$82.4M Hold
2,037,207
0.08% 133
2016
Q3
$77.8M Sell
2,037,207
-180,900
-8% -$7.26M 0.08% 137
2016
Q2
$92.8M Sell
2,218,107
-331,275
-13% -$13.6M 0.1% 128
2016
Q1
$102M Sell
2,549,382
-218,200
-8% -$8.77M 0.11% 130
2015
Q4
$118M Sell
2,767,582
-171,500
-6% -$7.89M 0.12% 118
2015
Q3
$140M Sell
2,939,082
-817,375
-22% -$41.6M 0.15% 112
2015
Q2
$186M Sell
3,756,457
-216,450
-5% -$11M 0.18% 104
2015
Q1
$196M Sell
3,972,907
-314,300
-7% -$15M 0.19% 102
2014
Q4
$196M Buy
4,287,207
+395,851
+10% +$19.2M 0.2% 98
2014
Q3
$220M Buy
3,891,356
+879,710
+29% +$47.2M 0.24% 87
2014
Q2
$160M Buy
3,011,646
+534,790
+22% +$28.4M 0.18% 97
2014
Q1
$129M Buy
2,476,856
+195,625
+9% +$9.9M 0.15% 110
2013
Q4
$122M Sell
2,281,231
-2,800
-0.1% -$144K 0.15% 106
2013
Q3
$116M Buy
2,284,031
+99,800
+5% +$5.08M 0.15% 103
2013
Q2
$113M Buy
+2,184,231
New +$116M 0.16% 98

Other funds holding SNY

Primecap Management's SNY Position: Q2 2026 in Review

Primecap Management held its Sanofi (SNY) position steady in Q2 2026 at 97,168 shares worth $4.15M. The position accounts for ﹤0.01% of the portfolio, ranked #292.

Primecap Management first reported a position in SNY in Q2 2013 and has held it in 53 quarters since. The position peaked at $220M in Q3 2014. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Primecap Management held 97,168 shares of Sanofi worth $4.15M as of Q2 2026.
  • Primecap Management left its Sanofi share count unchanged in Q2 2026.
  • Sanofi made up ﹤0.01% of Primecap Management's portfolio in Q2 2026, its #292 holding.
  • Primecap Management first reported a position in Sanofi in Q2 2013 and has held it in 53 quarters since.
  • Primecap Management's Sanofi position peaked at $220M in Q3 2014.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Primecap Management's 13F filing for Q2 2026, filed 14 Aug 2026.